文献速递血栓与止血

可溶性P-选择素而非循环游离DNA是肝素诱导性血小板减少症的潜在诊断生物标志物

Soluble P-selectin, but not circulating cell-free DNA, is a potential diagnostic biomarker in heparin-induced thrombocytopenia.
PubMed 文献 · J Thromb Haemost · 2025-04-17

单中心横断面回顾性研究纳入144例患者(69例确诊HIT、39例排除HIT、11例双阴性)及26例健康对照,评估41种免疫血栓标志物和循环游离DNA。可溶性P-选择素是唯一能区分PF4+/SRA+患者与其余各组及对照的标志物(P < .001),其AUC为0.83,联合PF4 ELISA后AUC提升至0.88(灵敏度82.6%,特异度87.2%)。结论认为HIT产生显著免疫血栓反应,sP-选择素是潜在诊断生物标志物。

要点

  • 可溶性P-选择素是唯一能区分PF4+/SRA+与PF4+/SRA-、PF4-/SRA-及对照的标志物(P < .001)。
  • sP-选择素AUC为0.83,联合PF4 ELISA后AUC为0.88(灵敏度82.6%,特异度87.2%)。
  • 多因素分析显示可溶性P-选择素与HIT独立相关。

核心结论

  • HIT产生显著的免疫血栓反应,可溶性P-选择素是该病诊断的潜在生物标志物。

研究设计与样本

  • 单中心横断面回顾性研究,纳入144例患者:69例确诊HIT(PF4+/SRA+)、39例排除HIT(PF4+/SRA-)、11例双阴性(PF4-/SRA-),另纳入26例健康志愿者作为对照。
  • 采用多重组阵列和ELISA评估41种免疫血栓生物标志物,用数字PCR定量循环游离DNA。

主要发现

  • 与健康对照相比,HIT患者D-二聚体和可溶性血栓调节蛋白水平升高、ADAMTS-13降低,符合促凝状态。
  • 可溶性黏附分子(sICAM-1、sVCAM-1)、细胞因子(IL-6、IL-8)、血小板活化标志物(sP-选择素、TXB2、sFcγRIIA)、内皮活化标志物(血管生成素-2)以及线粒体和基因组ccf-DNA均升高,提示促血栓表型。
  • sP-选择素是唯一能区分PF4+/SRA+患者与PF4+/SRA-、PF4-/SRA-及对照的标志物(P < .001)。
  • TXB2可区分PF4+/SRA+与PF4+/SRA-,但不能区分其他两组。
  • ROC分析显示P-选择素AUC为0.83,PF4 ELISA为0.80;两者联合AUC提升至0.88(灵敏度82.6%,特异度87.2%)。

关键数值与推荐

  • sP-选择素区分PF4+/SRA+与其余各组及对照的P < .001。
  • sP-选择素AUC为0.83,PF4 ELISA AUC为0.80。
  • sP-选择素联合PF4 ELISA的AUC为0.88,灵敏度82.6%,特异度87.2%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Heparin-induced thrombocytopenia (HIT) is characterized by the presence of anti-platelet factor 4 (PF4) antibodies, which bind to platelets via Fcγ receptor IIA (FcγRIIA), potentially leading to thrombosis. OBJECTIVES: To identify novel immunothrombosis markers and assess their diagnostic utility in HIT. METHODS: A single-center cross-sectional retrospective study was performed including 144 patients from a cohort that included 69 confirmed HIT patients (PF4+/serotonin release assay [SRA] +), 39 patients in whom HIT was excluded (PF4+/SRA-), and 11 patients negative by both screening and confirmatory tests (PF4-/SRA-). Additionally, 26 healthy volunteers were included as controls. We utilized multiplex arrays and ELISA to evaluate 41 biomarkers of immunothrombosis and digital PCR to quantify circulating cell-free DNA (ccf-DNA). RESULTS: Compared with healthy controls, HIT patients showed increased levels of D-dimer and soluble thrombomodulin, but reduced ADAMTS-13, consistent with a procoagulant status. Soluble adhesion molecules (soluble intercellular adhesion molecule-1, soluble vascular cell adhesion molecule-1), cytokines (interleukin [IL]-6, IL-8), and markers of platelet (sP-selectin, thromboxane 2 [TXB2], sFcγRIIA) and endothelium activation (angiopoietin-2), along with mitochondrial and genomic ccf-DNA, were elevated, implying a prothrombotic phenotype. Notably, sP-selectin was the only marker that differentiated PF4+/SRA+ patients from PF4+/SRA- and PF4-/SRA- patients and controls (P < .001). TXB2 also distinguished PF4+/SRA+ from PF4+/SRA- but not from the other 2 groups. Receiver operating characteristic analysis yielded an area under curve (AUC) of 0.83 for P-selectin and 0.80 for PF4 ELISA. Combining P-selectin and PF4 ELISA improved AUC to 0.88 (82.6% sensitivity, 87.2% specificity). Multivariate analysis revealed that soluble P-selectin is independently associated with HIT. CONCLUSION: HIT results in significant immunothrombotic responses, with sP-selectin as potential biomarker for the diagnosis of this condition.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Ramadan SS, Vaidya D, Dane KE, et al. Soluble P-selectin, but not circulating cell-free DNA, is a potential diagnostic biomarker in heparin-induced thrombocytopenia. J Thromb Haemost. 2025. PMID: 40252846. doi:10.1016/j.jtha.2025.04.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。